Fundraising

HK-based biotech startup gets venture capital injection

Insilico Medicine wants to speed up the process of drug development with its AI technology - and it is already doing so with the help of WuXi AppTech.
September 10, 2019

Qiming Venture Partners has led Series B fundraising for Hong Kong-based Insilico Medicine, which hopes to speed up the process of drug development with artificial intelligence.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media